ESMO Magnitude of Clinical Benefit Scale: News & Editorials

Keep up to date with the latest news and articles about the ESMO Magnitude of Clinical Benefit Scale

April 2017

Industry corner: perspectives and controversies - The challenges of patient access to new medicines
Article published in Annals of Oncology, Volume 28, Issue 3, March 2017

March 2017

Low-value practices in oncology contributing to financial toxicity
Article published in ecancermedicalscience, 16 March 2017

February 2017

Comparing assessment frameworks for cancer drugs between Canada and Europe: What can we learn from the differences?
Article published in ESMO Open, 22 February 2017

Cancer Drugs, Survival and Ethics: a Critical Look from the Inside 
Article published in ESMO Open, 10 February 2017

Clinical Benefit, Price and Approval Characteristics of FDA-approved New Drugs for Treating Advanced Solid Cancer, 2000-2015
Article published in Annals of Oncology, 8 February 2017

December 2016

Cancer Costs Leaving Patients in Debt 
ESMO Asia 2016 Press Release published 18 December 2016

November 2016

Judging Cancer Drugs by Clinical, Not Statistical, Measures – Big Trials Aiming for Small Effects
Article published by Medscape, 4 November 2016 (You will need to be logged in to Medscape, but accounts are free.)

October 2016

Do Contemporary Randomized Controlled Trials Meet ESMO Thresholds for Meaningful Clinical Benefit?
Article published in Annals of Oncology, 13 October 2016

First Feasibility Study of the ESMO-MCBS Scale in Rare Tumour Entities
ESMO Press Release published 10 October 2016

September 2016

Launch of First eUpdate Integrating Breakthroughs in ESMO Clinical Practice Guidelines
ESMO Press Release published 19 September 2016 introducing first eUpdate including ESMO-MCBS table

July 2016

Results of First Study Assessing Clinical Impact of ESMO-MCBS 
ESMO Press Release published 7 July 2016 

The European Society for Medical Oncology Magnitude of Clinical Benefit Scale in daily practice: a single institution, real-life experience at the Medical University of Vienna Authors: Barbara Kiesewetter, Markus Raderer, Günther G Steger, Rupert Bartsch, Robert Pirker, Sabine Zöchbauer-Müller, Gerald Prager, Michael Krainer, Matthias Preusser, Manuela Schmidinger, Christoph C Zielinski
Article published in ESMO Open, 4 July 2016

Applying the ESMO-Magnitude of Clinical Benefit Scale in Real Life 
Authors: Fortunato Ciardiello, Josep TaberneroEditorial published in ESMO Open, 4 July 2016

January 2016

Reply to the letter to the editor 'The ESMO Magnitude of Clinical Benefit Scaling Tool: from theory to practice' by Hartmann and the letter 'Comment on ESMO Magnitude of Clinical Benefit Scale' by Muhonen et al.
Article published in Annals of Oncology, Volume 27, Issue 1, January 2016

November 2015

The ESMO magnitude of clinical benefit scaling tool: from theory to practice
Article published in Annals of Oncology, Volume 26, Issue 11, November 2015

October 2015

Sizing Up ESMO's Drug Benefit Scale
David Kerr talks to Nathan Cherny about the scale

Video published by Medscape, 12 October 2015 (You will need to be logged in to Medscape, but accounts are free.)

June 2015

Proven Efficacy, Equitable Access and Adjusted Pricing of Anti-Cancer Therapies: No  ́Sweetheart ́ Solution
Author: Josep Tabernero on behalf of the ESMO Executive Board
Editorial published in Annals of Oncology, 4 June 2015

Citations and metrics